NCT04923867View on ClinicalTrials.gov

Suturable DuraGen™ PMCF Study

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Cerebrospinal Fluid Leak
Interventions
DEVICE

Suturable DuraGen™

Suturable DuraGen™ Dural Regeneration Matrix, an absorbable implant for repair of dural defects.

Trial Locations (3)

32207

Baptist Medical Center, Jacksonville

80045

University of Colorado Anschutz Medical Campus, Aurora

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY